Peptides

Enhanced Green Fluorescent Protein, EGFP (200-208) - 1 mg

  • Cat.Number : AS-65302
  • Availability :
    In stock

Quantity

This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer.

Specifications

Chemistry
Sequence one letter code
  • HYLSTQSAL
Sequence three letter code
  • H-His-Tyr-Leu-Ser-Thr-Gln-Ser-Ala-Leu-OH
Molecular Formula
  • C45H70N12O15
Molecular Mass/ Weight
  • 1019.2
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
  • Peak Area by HPLC ≥95%
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • Jellyfish

You may also be interested in the following product(s)

IMG-EN-AS-60877-01.jpg

Thrombospondin (TSP-1) Inhibitor, LSKL - 1 mg

Cat.Number : AS-60877
$71.00 Excl. Tax

References

Captopril, an Angiotensin-Converting Enzyme Inhibitor, Promotes Growth of Immunogenic Tumors in Mice

Clin Cancer Res . 2006 Jul 01 ; 12(13) 4095 | DOI : 10.1158/1078-0432.CCR-05-2489

  • P. Wysocki
  • et al

High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged Animals

J Immunol . 2006 Dec 15 ; 177(12) 8348 | DOI : https://doi.org/10.4049/jimmunol.177.12.8348

  • S. Sharma
  • et al

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope

Gene Ther . 2000 Dec 04 ; 7(23) 2036 | DOI : https://doi.org/10.1038/sj.gt.3301335

  • A. Gambotto
  • et al

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO

Eur J Immunol . 2005 Dec 27 ; 36(1) 12 | DOI : https://doi.org/10.1002/eji.200535602

  • W. Wingender
  • et al